0001209191-23-056802.txt : 20231128
0001209191-23-056802.hdr.sgml : 20231128
20231128163016
ACCESSION NUMBER: 0001209191-23-056802
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231126
FILED AS OF DATE: 20231128
DATE AS OF CHANGE: 20231128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amello Jason
CENTRAL INDEX KEY: 0001451805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40629
FILM NUMBER: 231446874
MAIL ADDRESS:
STREET 1: 500 KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 01824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Candel Therapeutics, Inc.
CENTRAL INDEX KEY: 0001841387
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 522214851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
BUSINESS PHONE: 617-916-5445
MAIL ADDRESS:
STREET 1: 117 KENDRICK STREET
STREET 2: SUITE 450
CITY: NEEDHAM
STATE: MA
ZIP: 02494
FORMER COMPANY:
FORMER CONFORMED NAME: Candel Therapeutics, Inic.
DATE OF NAME CHANGE: 20210120
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-26
0
0001841387
Candel Therapeutics, Inc.
CADL
0001451805
Amello Jason
C/O CANDEL THERAPEUTICS, INC.
117 KENDRICK ST., SUITE 450
NEEDHAM
MA
02494
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-11-26
4
A
0
125717
0.00
A
222162
D
Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on June 30, 2024, and the remaining 50% on December 31, 2024, in each case subject to the Reporting Person's continued service on such vesting date.
/s/ Jason Amello
2023-11-28